Morning Market Movers By: Benzinga via Benzinga November 10, 2014 at 09:43 AM EST Cancer Genetics (NASDAQ: CGIX) shares climbed 28.33% to $7.70 on Q3 results. The company reported a Q3 loss of $0.41 per share on ... Read More >> Related Stocks: Achison Inc Arqule Inc Cancer Genetics Inc China Finance Online ADR Dean Foods Company Sotheby's Holdings